ArticleScientific reports2024

Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.

Shruti V Patil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.